Parkinson's disease and tea: A quantitative review

Journal of the American College of Nutrition

Volumn 28, Issue 1, 2009, Pages 1-6

  Quintana, José Luis Barranco ^a   Allam, Mohamed Farouk ^a   Del Castillo, Amparo Serrano ^a   Navajas, Rafael Fernández Crehuet ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Meta analysis; Parkinson's disease; Systematic review; Tea

Indexed keywords

ASIA; CASE CONTROL STUDY; CHINESE; CONSUMER; DISEASE ASSOCIATION; EUROPE; FOOD INTAKE; HUMAN; NORTH AMERICA; OBSERVATIONAL STUDY; PARKINSON DISEASE; POPULATION RESEARCH; PROTECTION; QUANTITATIVE ANALYSIS; REVIEW; RISK; RISK ASSESSMENT; TEA; BEVERAGE; CONFIDENCE INTERVAL; EPIDEMIOLOGY; ETHNOLOGY; PHYTOTHERAPY;

PLANT MEDICINAL PRODUCT;

ASIA; BEVERAGES; CONFIDENCE INTERVALS; EPIDEMIOLOGIC STUDIES; EUROPE; HUMANS; NORTH AMERICA; ODDS RATIO; PARKINSON DISEASE; PHYTOTHERAPY; PLANT PREPARATIONS; TEA;

EID: 69449103896     PISSN: 07315724     EISSN: None     Source Type: Journal    
DOI: 10.1080/07315724.2009.10719754     Document Type: Review

References (51)

1. Langston JW: Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann Neurol 44(Suppl 1):S45-S52, 1998.
2. Checkoway H, Nelson LM: Epidemiology approaches to the study of Parkinson's disease etiology. Epidemiology 10:327-336, 1999. (Pubitemid 29187771)
3. Morens DM, Grandinetti A, Reed D, White LR, Ross GW: Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology 45:1041-1451, 1995.
4. Fratiglioni L, Wang HX: Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies. Behav Brain Res 113:117-120, 2000. (Pubitemid 30645549)
5. Sugita M, Izuno T, Tatemichi M, Otahara Y: Meta-analysis for epidemiologic studies on the relationship between smoking and Parkinson's disease. J Epidemiol 11:87-94, 2001.
6. Ascherio A, Zhang SM, Hernán MA, Kawachi I, Colditz GA, Speizer FE, Willett WC: Prospective Study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 50:56-63, 2001. (Pubitemid 32591463)
7. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ: A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52:276-284, 2002. (Pubitemid 35001493)
8. Chan DK, Woo J, Ho SC, Pang CP, Law LK, Hung WT, Kwok T, Hui E, Orr K, Leung MF, Kay R: Genetic and environmental risk factors for Parkinson Disease in a Chinese population. J Neurol Neurosurg Psychiatry 65:781-784, 1998. (Pubitemid 28486664)
9. Sumpio BE, Cordova AC, Berke-Schlessel DW, Qin F, Chen QH: Green tea, the "Asian paradox", and cardiovascular disease. J Am Coll Surg 202:813-825, 2006.
10. Li Sc, Schoenberg BS, Wang CC, Cheng X-M, Rui D-Y, Bolis CL, Schoenberg BG: A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. Arch Neurol 42:655-657, 1985.
11. Zhang ZX, Roman GC: Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 12:195-208, 1993.
12. Haack DG, Baumann RJ, McKean HE, Jameson HD, Turbek JA: Nicotine exposure and Parkinson Disease. Am J Epidemiol 114: 191-200, 1981.
13. Ho SC, Woo J, Lee CM: Epidemiologic study of Parkinson's disease in Hong Kong. Neurology 39:1314-1318, 1989. (Pubitemid 19246803)
14. Zayed J, Ducic S, campanella G, Panisset JC, André P, Masson H, Roy M: Facteurs environnementaux dans l'étiologie de la maladie de Parkinson. Can J Neurol Sci 17:286-291, 1990.
15. Morano A, Jiménez-Jiménez FJ, Molina JA, Antolín MA: Risk factors for Parkinson's disease: case-control study in the province of Cáceres, Spain. Acta Neurol Scand 89:164-170, 1994. (Pubitemid 24133430)
16. Hellenbrand W, Seidler A, Boeing H, Robra BP, Vieregge P, Nischan P, Joerg J, Oertel WH, Schneider E, Ulm G: Diet and Parkinson's disease I: A possible role for the past intake of specific foods and foods groups. Neurology 47:636-643, 1996.
17. Fall PA, Fredrikson M, Axelson O, Granérus AK: Nutritional and occupational factors influencing the risk of Parkinson's disease: A case-control study in Southeastern Sweden. Mov Disord 14:28-37, 1999. (Pubitemid 29224673)
18. Preux PM, Condet A, Anglade C, Druet-Cabanac M, Debrock C, Macharia W, Couratier P, Boutros-Toni F, Dumas M: Parkinson's disease and environmental factors. Neuroepidemiology 19:333-337, 2000.
19. Paganini-Hill A: Risk factors for Parkinson's disease: the Leisure World cohort study. Neuroepidemiology 20:118-124, 2001. (Pubitemid 32453730)
20. Checkoway H, Powers K, Smith-Weller T, Franklin GM, Long-streth WT, Swanson PD: Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 155:732-738, 2002. (Pubitemid 34297653)
21. Tan EK, Tan C, Fook-Chong SM, Lum SY, Chai A, Chung H, Shen H, Zhao Y, Teoh ML, Yih Y, Pavanni R, Chandran VR, Wong MC: Dose-dependent protective effect of coffee, tea, and smoking in Parkinson disease: a study in ethnic Chinese. J Neurol Sci 216:163-167, 2003. (Pubitemid 37376408)
22. Fleiss JL: The statistical basis of meta-analysis. Stat Methods Med Res 2:121-145, 1993.
23. DerSimonian R, Laird N: Meta-analysis in clinical trials. Contr Clin Trials 7:177-188, 1986.
24. Greenland S: Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9:1-30, 1987.
25. Rosenthal R: The 'File Drawer Problem' and tolerance for null results. Psychol Bull 86:638-641, 1979.
26. Kuopio AM, Marttila RJ, Helenius H, Rinne UK: Environmental risk factors in Parkinson's disease. Mov Disord 14:928-939, 1999.
27. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P: Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 56:730-736, 2001. (Pubitemid 32240091)
28. Costa-Mallen P, Checkoway H, Fishel M, Cohen AW, Smith-Weller T, Franklin GM: The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease. Neurosci Lett 278:33-36, 2000. (Pubitemid 30009890)
29. Nefzger MD, Quadfasel FA, Karl VC: A retrospective study of smoking in Parkinson's disease. Am J Epidemiol 88:149-158, 1968.
30. Benedetti MD, Boewr JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Ahlskog JE, Schaid DJ, Rocca WA: Smoking, alcohol, and coffee consumption preceding Parkinson's disease. A case-control study. Neurology 55:1350-1358, 2000.
31. Ross GW, Abbott RD, Petrovitch H, White LR, Tanner CM: Relationship between caffeine intake and Parkinson disease JAMA 284:1378-1379, 2000.
32. Fink JS, Bains LA, Beiser A, Seshadri S, Wolf PA: Caffeine intake and the risk of incident Parkinson's disease: the Framingham Study. Mov Disord 16:984, 2001.
33. Pan T, Jankovic J, Le W: Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging 20:711-721, 2003. (Pubitemid 36995249)
34. +-induced dopamine neuron injury. Life Sci 72:1073-1083, 2004.
35. Yoneda T, Hiramatsu M, Skamoto N, Togasaki K, Komatsu M, Yamaguchi K: Antioxidant effects of "β-Catechin". Biochem Mol Biol Int 35:995-1008, 1995.
36. Dong ZG, Ma WY, Huang ZS, Yang ZS: Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols,(-) epigallocatechin gallate and theaflavins. Cancer Res 57:4414-4419, 1997.
37. Frei B, Higdon JV: Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133:3275S-3284S, 2003. (Pubitemid 37222256)
38. Higdon JV, Frei B: Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43:89-143, 2003.
39. Weinreb O, Mandel S, Amit T, Youdim MB: Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J Nutr Biochem 15:506-516, 2004. (Pubitemid 39209392)
40. Soto-Otero R, Méndez-Álvarez E, Hermida-Ameijeiras Á, Muñoz Patiño AM, Labaneira-García JL: Autoxidation and neurotoxicity of 6-hydrodoe in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem 74:1605-1612, 2000. (Pubitemid 30163982)
41. Levites Y, Youdin MB, Maor G, Mandel S: Attenuation of 6-hidoxydopamine (6-OHDA)-induced nuclear factor-kappaB (NFKB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 63:21-29, 2004. (Pubitemid 34075289)
42. Allam MF, Del Castillo AS, Navajas RF-C: Smoking and Parkinson's disease: explanatory hypothesis. Int J Neurosci 112:851-854, 2002.
43. Yang F, de Villiers WJ, McClain CJ, Varilek GW: Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 128:2334-2340, 1998. (Pubitemid 29012980)
44. Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM: Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 308:767-773, 2004. (Pubitemid 38134242)
45. Il'yasova D, Martin C, Sandler RS: Tea intake and risk of colon cancer in African-Americans and whites: North Carolina colon cancer study. Cancer Causes Control 14:767-772, 2003.
46. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J: Cholesterol lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 163:1448-1453, 2003. (Pubitemid 36758917)
47. Maron DJ: Flavonoids for education of atherosclerotic risk. Curr Atheroscler Rep 6:73-78, 2004.
48. Negishi H, Xu JW, Ikeda K, Njelekela M, Nara Y, Yamori Y: Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr 134:38-42, 2004. (Pubitemid 38057420)
49. Ju J, Liu Y, Hong J, Huang MT, Conney AH, Yang CS: Effects of green tea and high fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethane-induced colon carcinogenesis mouse model. Nutr Cancer 46:172-178, 2004. (Pubitemid 37500509)
50. Sesso HD, Gaziano JM, Liu S, Buring JE: Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 79:522-523, 2004. (Pubitemid 38196722)
51. Zhou JR, Yu L, Mai Z, Blackburn GL: Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int J Cancer 108:8-14, 2004 (Pubitemid 37444437)